Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Litx BPH System in LUTS due to BPH
NCT00918034Phase 2Completed
- Sponsor
- Light Science Oncology
- Start
- May 2009
- Primary completion
- Feb 2011
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of talaporfin sodium in benign prostatic hyperplasia (BPH), sponsored by Light Science Oncology. Started May 2009; status: completed.
02
Drugs
talaporfin sodium
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00918034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00918034.